by Denise Purdie Andrews | May 5, 2023 | Drug Classes
By Stuart Kurtz, M.S. D-ABFT-FT The purpose of these next two blog posts is to discuss the utility that vitreous humor provides in the context of a case. This first post will focus on what vitreous humor is and the caveats associated with its interpretation. The...
by Denise Purdie Andrews | Mar 2, 2023 | Drug Classes
The purpose of this blog post is to take a look at some of our data regarding nitazene detections. For some background on nitazene compounds, take a look at our blog post of June 9, 2022 titled Drug Primer: Nitazenes. As a reminder, nitazenes are a structurally...
by Denise Purdie Andrews | Feb 7, 2023 | Drug Classes, General
Kevin Shanks presented on Fluorofentanyl at the Society of Forensic Toxicologists (SOFT) annual meeting in Cleveland, OH. The title of the talk is below and the abstract is available upon request. Fluorofentanyl Detection by LC-QToFMS & Prevalence in Postmortem...
by Denise Purdie Andrews | Jan 3, 2023 | Drug Classes
In October, toxicologist Stuart Kurtz presented a poster at the annual National Association of Medical Examiners (NAME) meeting in Dallas, TX. The abstract is below. A Case Report Involving the Detection of Five New Psychoactive Substances in Postmortem Analysis. ...
by Denise Purdie Andrews | Nov 29, 2022 | Drug Classes
Dr. George Behonick presented the following poster at the annual NAME meeting in Dallas, TX. This is the first of several articles to share recent presentations by our toxicologists. Postmortem Redistribution of Fentanyl as Evidenced by Central and Peripheral Blood...
by Denise Purdie Andrews | Jun 9, 2022 | Drug Classes
By Kevin Shanks, D-ABFT-FT Over the last several years, the Drug Enforcement Administration (DEA) has moved to ban various newly emerged illicit opioids as Schedule I controlled substances. From 2015-2017, they controlled 19 fentanyl analogs and other opioids. In...
